Yannick Renaud

679 total citations
8 papers, 440 citations indexed

About

Yannick Renaud is a scholar working on Pharmacology, Physiology and Molecular Biology. According to data from OpenAlex, Yannick Renaud has authored 8 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Yannick Renaud's work include Pharmacogenetics and Drug Metabolism (3 papers), Computational Drug Discovery Methods (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Yannick Renaud is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Computational Drug Discovery Methods (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Yannick Renaud collaborates with scholars based in Canada, United States and Spain. Yannick Renaud's co-authors include Thomas J. Hudson, Janet Faith, Catherine Laprise, Mathieu Lemire, Benjamin A. Raby, Michael Phillips, David Altshuler, Leif Groop, Pierre Lepage and Scott M. Williams and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Diabetes and Clinical Pharmacology & Therapeutics.

In The Last Decade

Yannick Renaud

8 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yannick Renaud Canada	7	196	145	110	80	73	8	440
Paul D. Freeswick United States	11	99 0.5×	75 0.5×	135 1.2×	36 0.5×	11 0.2×	12	499
Yoshihiro Kawamura Japan	13	63 0.3×	88 0.6×	9 0.1×	18 0.2×	32 0.4×	33	499
Jinxiu Li China	12	56 0.3×	81 0.6×	115 1.0×	15 0.2×	6 0.1×	34	592
Benedetta Lunghi Italy	11	116 0.6×	35 0.2×	50 0.5×	8 0.1×	13 0.2×	13	521
H. Ditschuneit Germany	16	155 0.8×	134 0.9×	31 0.3×	4 0.1×	14 0.2×	58	801
Yufeng Li China	11	38 0.2×	40 0.3×	74 0.7×	7 0.1×	13 0.2×	34	371
Ömer Şentürk Türkiye	14	36 0.2×	357 2.5×	30 0.3×	60 0.8×	3 0.0×	44	652
Rei‐Hwa Lu Taiwan	12	74 0.4×	437 3.0×	51 0.5×	43 0.5×	8 0.1×	22	678
Manuel Macı́a Spain	11	52 0.3×	70 0.5×	30 0.3×	12 0.1×	4 0.1×	30	757
Malcolm S. Ogg United Kingdom	6	38 0.2×	105 0.7×	89 0.8×	91 1.1×	3 0.0×	7	329

Countries citing papers authored by Yannick Renaud

Since Specialization

Citations

This map shows the geographic impact of Yannick Renaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannick Renaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannick Renaud more than expected).

Fields of papers citing papers by Yannick Renaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannick Renaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannick Renaud. The network helps show where Yannick Renaud may publish in the future.

Co-authorship network of co-authors of Yannick Renaud

This figure shows the co-authorship network connecting the top 25 collaborators of Yannick Renaud. A scholar is included among the top collaborators of Yannick Renaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannick Renaud. Yannick Renaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Brown, Andrew, Yannick Renaud, Colin J.D. Ross, et al.. (2014). Development of a Broad-Based ADME Panel for Use in Pharmacogenomic Studies. Pharmacogenomics. 15(9). 1185–1195. 9 indexed citations

2.

King, Cristi R., Rhonda Porche-Sorbet, Brian F. Gage, et al.. (2008). Performance of Commercial Platforms for Rapid Genotyping of Polymorphisms Affecting Warfarin Dose. American Journal of Clinical Pathology. 129(6). 876–883. 46 indexed citations

3.

Brouillette, Dany, Denis Roy, Lucie Verret, et al.. (2007). Combination of Phenotype Assessments and CYP2C9-VKORC1 Polymorphisms in the Determination of Warfarin Dose Requirements in Heavily Medicated Patients. Clinical Pharmacology & Therapeutics. 83(5). 740–748. 40 indexed citations

4.

Tremblay, Karine, Mathieu Lemire, Tomi Pastinen, et al.. (2006). Association study between the CX3CR1 gene and asthma. Genes and Immunity. 7(8). 632–639. 34 indexed citations

5.

Hilton, John, Karen E. Christensen, David Watkins, et al.. (2003). The molecular basis of glutamate formiminotransferase deficiency. Human Mutation. 22(1). 67–73. 40 indexed citations

6.

Hilton, John, Karen E. Christensen, David Watkins, et al.. (2003). The molecular basis of glutamate formiminotransferase deficiency. Human Mutation. 22(5). 416–416. 1 indexed citations

7.

Raby, Benjamin A., Walter T. Klimecki, Catherine Laprise, et al.. (2002). Polymorphisms in Toll-Like Receptor 4 Are Not Associated with Asthma or Atopy-related Phenotypes. American Journal of Respiratory and Critical Care Medicine. 166(11). 1449–1456. 132 indexed citations

8.

Engert, James C., Marie‐Claude Vohl, Scott M. Williams, et al.. (2002). 5′ Flanking Variants of Resistin Are Associated With Obesity. Diabetes. 51(5). 1629–1634. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact